| Title |
Bisphosphonates for osteoporosis in primary biliary cirrhosis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2011
|
| DOI | 10.1002/14651858.cd009144.pub2 |
| Pubmed ID | |
| Authors |
Jelena S Rudic, Vanja Giljaca, Miodrag N Krstic, Goran Bjelakovic, Christian Gluud |
| Abstract |
Bisphosphonates are widely used for treatment of postmenopausal osteoporosis. Patients with primary biliary cirrhosis often have osteoporosis - either postmenopausal or secondary to the liver disease. No systematic review or meta-analysis has assessed the effects of bisphosphonates for osteoporosis in patients with primary biliary cirrhosis. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 172 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 170 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 25 | 15% |
| Student > Bachelor | 22 | 13% |
| Researcher | 17 | 10% |
| Student > Ph. D. Student | 16 | 9% |
| Student > Postgraduate | 11 | 6% |
| Other | 40 | 23% |
| Unknown | 41 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 79 | 46% |
| Nursing and Health Professions | 12 | 7% |
| Unspecified | 8 | 5% |
| Agricultural and Biological Sciences | 5 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Other | 13 | 8% |
| Unknown | 50 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2021.
All research outputs
#17,351,840
of 25,461,852 outputs
Outputs from Cochrane database of systematic reviews
#10,863
of 12,090 outputs
Outputs of similar age
#172,316
of 247,377 outputs
Outputs of similar age from Cochrane database of systematic reviews
#167
of 216 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,377 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 216 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.